Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes.
about
Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypesViral evolution and escape during acute HIV-1 infectionImpact of human immunodeficiency virus type-1 sequence diversity on antiretroviral therapy outcomesSIV genome-wide pyrosequencing provides a comprehensive and unbiased view of variation within and outside CD8 T lymphocyte epitopesIdentification of a cluster of HIV-1 controllers infected with low replicating virusesIncreased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.HIV-1 epidemic in the Caribbean is dominated by subtype B.Complete viral RNA genome sequencing of ultra-low copy samples by sequence-independent amplificationElite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kineticsUnexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replicationAmino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamics.Impaired replication capacity of acute/early viruses in persons who become HIV controllers.Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers.Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllersImpact of HLA selection pressure on HIV fitness at a population level in Mexico and Barbados.Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infectionHIV-1 continues to replicate and evolve in patients with natural control of HIV infectionCD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study.Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients.Nef-specific CD8+ T cell responses contribute to HIV-1 immune control.Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.Coordinate linkage of HIV evolution reveals regions of immunological vulnerability.Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses.Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllersModest attenuation of HIV-1 Vpu alleles derived from elite controller plasmaComparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children.Differential Ability of Primary HIV-1 Nef Isolates To Downregulate HIV-1 Entry Receptors.HIV pathogenesis: the host.Intersubtype differences in the effect of a rare p24 gag mutation on HIV-1 replicative fitness.TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infectionHost factors dictate control of viral replication in two HIV-1 controller/chronic progressor transmission pairs.Significant reductions in Gag-protease-mediated HIV-1 replication capacity during the course of the epidemic in JapanNef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular CytotoxicityFrequent Genetic Defects in the HIV-1 5' LTR/gag Gene in Hemophiliacs Treated with Korean Red Ginseng: Decreased Detection of Genetic Defects by Highly Active Antiretroviral Therapy.Impact of pre-adapted HIV transmission.Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral ReactivationNatural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulationEvidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy.
P2860
Q21245213-2FC4CD33-F9FD-442F-8CFB-07CF92465F2EQ24600713-53BD251D-422C-4F2D-AE78-2247ADA4C74AQ26851997-93F7C211-7B1C-4297-AB25-F6D12DCB0BE8Q27313564-CCE108A4-A362-4EB3-B715-1394A08DE119Q28534737-102C6653-DD10-4895-8FDA-69D1C3E3C9DAQ30372415-19AAF5DB-BEC1-4214-B805-41C957E73EB4Q30375505-2F5B8CEC-145E-4114-8AC8-9ACF406B671AQ30421085-DE94831D-8BBB-4FD1-9C8E-3489964EB506Q33429049-390B255B-B912-4D1A-A744-7EC0225D9483Q33631183-C902E967-10B3-438A-ABD8-95A122263C64Q33687232-C498C2C6-C5C9-4F17-979E-492AD0F436DAQ33963989-DD0965E7-A2FB-44C6-8AE7-B51312E84913Q34083315-A63ACB7C-A5EF-4388-91EC-F0066DF9B924Q34120046-8128848D-6D40-45DF-8CF0-E062F23BB9F9Q34262204-04EACA41-9503-48BC-AAEB-2EA58C2396BFQ34295972-DABCBF07-A044-4073-91F5-3D6BBCB10BAFQ34416428-C2FA6211-AA59-4476-A6AC-8332F1F2B034Q34677320-54B9D326-C509-4478-BC91-E05BC8FF0D46Q34740235-BDF17858-3676-4144-9FE8-9A0F3E00EEAEQ34874985-A265AF47-815B-42EC-AD5B-9D40898A697DQ34984237-A035BB66-98FE-4271-8C36-919DD2F463C5Q35001377-8B1AA4E1-3CAA-4264-918D-E89EE94A03A6Q35007339-6D001A0F-435C-4726-870A-D8C28E07A0EAQ35105172-5C0FEC0A-168E-4AA7-B145-69CCA513C458Q35487807-25FF9172-4F14-452A-8381-F4C41264AD8FQ35489088-71C7AF27-3006-47F1-9A9F-317474D0F7E0Q35582429-8FD71BBA-F739-4BDD-96C9-9F5F64ACB324Q35758499-03716E15-5DBE-4DAD-89A2-6BB5142AE60FQ35973681-EDF5A4D3-EB8D-4874-9A66-F6D7563BFC68Q36186538-97E25673-2E57-49F9-ACEE-54BD9E9CA0F0Q36414578-1BE433AB-1E7D-45C2-A0EA-035776FECB38Q36513955-234C55EE-F7FC-413E-AE15-D2CFE7291C7EQ36547178-3008C083-65F7-4DE1-A9CF-DF9C869F5ED5Q36559805-0B6812E5-226A-45D0-914A-2FACCD83181AQ36736588-4A87506E-A08D-4391-8E7C-5D34154F28DDQ36860995-9FE6B729-38E2-4FE0-AE40-032054574C27Q36984267-D449A34D-CE92-4E2B-AB4F-979D188A78B4Q37002564-CD03CBB6-3119-4795-A31A-08D90CE5953CQ37031810-F9C2F10D-0D1C-4B65-93E5-E1F46E0972EBQ37033224-78A31A54-1723-432A-A6DF-FFAFA592222F
P2860
Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Genetic characterization of hu ...... or common amino acid changes.
@en
type
label
Genetic characterization of hu ...... or common amino acid changes.
@en
prefLabel
Genetic characterization of hu ...... or common amino acid changes.
@en
P2093
P2860
P50
P356
P1433
P1476
Genetic characterization of hu ...... or common amino acid changes.
@en
P2093
Alissa C Rothchild
Arne Schneidewind
Brett M Baker
Brian L Block
Jonathan M Carlson
Marylyn M Addo
Theresa Flynn
Toshiyuki Miura
Yaoyu E Wang
P2860
P304
P356
10.1128/JVI.00535-08
P407
P50
P577
2008-06-18T00:00:00Z